Acetylcholine Receptor Gating: Movement in the {alpha}-Subunit Extracellular Domain.

Acetylcholine Receptor Gating: Movement in the {alpha}-Subunit Extracellular Domain. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Acetylcholine Receptor Gating: Movement in the {alpha}-Subunit Extracellular Domain. Abstract Text:

Prasad Purohit,Anthony Auerbach,Prasad Purohit,Anthony Auerbach,

Acetylcholine receptor channel gating is a brownian conformational cascade in which nanometer-sized domains ("Phi blocks") move in staggering sequence to link an affinity change at the transmitter binding sites with a conductance change in the pore. In the alpha-subunit, the first Phi-block to move during channel opening is comprised of residues near the transmitter binding site and the second is comprised of residues near the base of the extracellular domain. We used the rate constants estimated from single-channel currents to infer the gating dynamics of Y127 and K145, in the inner and outer sheet of the beta-core of the alpha-subunit. Y127 is at the boundary between the first and second Phi blocks, at a subunit interface. alphaY127 mutations cause large changes in the gating equilibrium constant and with a characteristic Phi-value (Phi = 0.77) that places this residue in the second Phi-block. We also examined the effect on gating of mutations in neighboring residues deltaI43 (Phi = 0.86), epsilonN39 (complex kinetics), alphaI49 (no effect) and in residues that are homologous to alphaY127 on the epsilon, beta, and delta subunits (no effect). The extent to which alphaY127 gating motions are coupled to its neighbors was estimated by measuring the kinetic and equilibrium constants of constructs having mutations in alphaY127 (in both alpha subunits) plus residues alphaD97 or deltaI43. The magnitude of the coupling between alphaD97 and alphaY127 depended on the alphaY127 side chain and was small for both H (0.53 kcal/mol) and C (-0.37 kcal/mol) substitutions. The coupling across the single alpha-delta subunit boundary was larger (0.84 kcal/mol). The Phi-value for K145 (0.96) indicates that its gating motion is correlated temporally with the motions of residues in the first Phi-block and is not synchronous with those of alphaY127. This suggests that the inner and outer sheets of the alpha-subunit beta-core do not rotate as a rigid body.

Acetylcholine Receptor Gating: Movement in the {alpha}-Subunit Extracellular Domain. Publishing Authors By Initials

P Purohit,A Auerbach,P Purohit,A Auerbach,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Acetylcholine Receptor Gating: Movement in the {alpha}-Subunit Extracellular Domain. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: The Journal of general physiology

VOLUME: 130

Page Numbers: 569-79

Journal Abbreviation: J. Gen. Physiol.

ISSN: 0022-1295

DAY: 27

MONTH: Dec

YEAR: 2007

Acetylcholine Receptor Gating: Movement in the {alpha}-Subunit Extracellular Domain. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 2985110

Acetylcholine Receptor Gating: Movement in the {alpha}-Subunit Extracellular Domain. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Acetylcholine Receptor Gating: Movement in the {alpha}-Subunit Extracellular Domain. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Acetylcholine Receptor Gating: Movement in the {alpha}-Subunit Extracellular Domain.

AFFILIATION: Correspondence to Anthony Auerbach: auerbach@buffalo.edu.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Gen Physiol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Acetylcholine Receptor Gating: Movement in the {alpha}-Subunit Extracellular Domain Related Publications

• A molecular scheme for improved characterization of human embryonic stem cell lines.
• Acetylcholine Receptor Gating: Movement in the {alpha}-Subunit Extracellular Domain.
• Acetylcholine receptor gating at extracellular transmembrane domain interface: the "pre-m1" linker.
• Acetylcholine receptor gating at extracellular transmembrane domain interface: the cys-loop and m2 m3 linker.
• An advanced molecule-surface scattering instrument for study of vibrational energy transfer in gas-solid collisions.
• Anesthesia in endodontia.
• Chemical mutagenesis.
• Determination of homosulfanilamide hydrochloride, with observations on its absorption in dogs and man.
• Directory of organizations in America, of and for the deaf.
• Emphysema: smoking's irreversible legacy.
• Empyema as a complication of chronic pulmonary tuberculosis.
• Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer.
• How to turn the reaction coordinate into time.
• Impact of reliance on CT pulmonary angiography on diagnosis of pulmonary embolism: a Bayesian analysis.
• Microwave-driven zeolite-guest systems show athermal effects from nonequilibrium molecular dynamics.
• Nociceptin/orphanin FQ decreases serotonin efflux in the rat brain but in contrast to a kappa-opioid has no antagonistic effect on mu-opioid-induced increases in serotonin efflux.
• Operationalizing the "vulnerability" and "stress" components of the hopelessness theory of depression: a multi-wave longitudinal study.
• Outcomes of care by hospitalists, general internists, and family physicians.
• Physiology of the pulpless tooth; is the pulpless tooth a dead tooth?
• Primary motor area activation during precision-demanding versus simple finger movement.
• Production of functional transgenic mice by DNA pronuclear microinjection.
• Pyrazole inhibitors of HMG-CoA reductase: an attempt to dramatically reduce synthetic complexity through minimal analog re-design.
• Qualification of embryonal carcinoma 2102Ep as a reference for human embryonic stem cell research.
• Responses to depression in children: reconceptualizing the relation among response styles.
• THE METABOLISM OF HISTIDINE. VI. HISTIDINEMIA AND IMIDAZOLEPYRUVIC ACIDURIA.
• The action of cationic detergents on bacteria and bacterial enzymes.
• The pathology of carcinoma of the bronchus.
• The relevance and future of wilderness medicine.
• Tuberculosis in children.
• Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia.